Pharmaceutical Compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090253718A1
SERIAL NO

12298117

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a compound having the formula (I):are each independently selected from hydrogen and various substituents as defined in the claims, wherein the compound is for use in: (a) the treatment or prophylaxis of a disease or condition in which the modulation (e.g. inhibition) of ROCK kinase or protein kinase p70S6K is indicated; and/or (b) the treatment of a subject or patient population in which the modulation (e.g. inhibition) of ROCK kinase or protein kinase p70S6K is indicated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER RESEARCH TECHNOLOGY LIMITEDANGEL BUILDING 407 ST JOHN STREET LONDON EC1V4AD
ASTEX THERAPEUTICS LIMITEDCAMBRIDGE CAMBRIDGESHIRE CB4 0QA
THE INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL123 OLD BROMPTON ROAD LONDON SW7 3RP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boyle, Robert George Cambridge , GB 36 393
Collins, Ian Redhill , GB 93 1712
Davies, Thomas Glanmor Cambridge , GB 7 35
Garrett, Michelle Dawn Surrey , GB 8 60

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation